• Physiotherapist-led treatment for femoroacetabular impingement syndrome (the PhysioFIRST study): a protocol for a participant and assessor-blinded randomised controlled trial 

  Kemp, JL; Johnston, RTR; Coburn, SL; Jones, DM; Schache, AG; Mentiplay, BF; King, MG; Scholes, MJ; De Oliveira Silva, D; Smith, A; ... (BMJ PUBLISHING GROUP, 2021-01-01)

  INTRODUCTION: This double-blind, randomised controlled trial (RCT) aims to estimate the effect of a physiotherapist-led intervention with targeted strengthening compared with a physiotherapist-led intervention with ...

• MASI: microbiota-active substance interactions database. 

  Zeng, X; Yang, X; Fan, J; Tan, Y; Ju, L; Shen, W; Wang, Y; Wang, X; Chen, W; Ju, D; ... (Oxford University Press (OUP), 2021-01-08)

  Xenobiotic and host active substances interact with gut microbiota to influence human health and therapeutics. Dietary, pharmaceutical, herbal and environmental substances are modified by microbiota with altered ...

• Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. 

  Wang, Y; Zhang, S; Li, F; Zhou, Y; Zhang, Y; Wang, Z; Zhang, R; Zhu, J; Ren, Y; Tan, Y; ... (Oxford University Press (OUP), 2020-01-08)

  Knowledge of therapeutic targets and early drug candidates is useful for improved drug discovery. In particular, information about target regulators and the patented therapeutic agents facilitates research regarding ...

View more